Author Correction: A practical guide for mutational signature analysis in hematological malignancies

Francesco Maura; Andrea Degasperi; Ferran Nadeu; Daniel Leongamornlert; Helen Davies; Luiza Moore; Romina Royo; Bachisio Ziccheddu; Xose S Puente; Herve Avet-Loiseau; Peter J Campbell; Serena Nik-Zainal; Elias Campo; Nikhil Munshi; Niccolò Bolli

doi:10.1038/s41467-019-11468-3

Author Correction: A practical guide for mutational signature analysis in hematological malignancies

Nat Commun. 2019 Jul 25;10(1):3431. doi: 10.1038/s41467-019-11468-3.

Authors

Francesco Maura^{1

2

3}, Andrea Degasperi^{4

5

6}, Ferran Nadeu^{7

8}, Daniel Leongamornlert⁴, Helen Davies^{4

5

6}, Luiza Moore⁴, Romina Royo⁹, Bachisio Ziccheddu¹⁰, Xose S Puente^{11

12}, Herve Avet-Loiseau¹³, Peter J Campbell⁴, Serena Nik-Zainal^{4

5

6}, Elias Campo^{7

8

9}, Nikhil Munshi^{14

15}, Niccolò Bolli^{16

17}

Affiliations

¹ Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, 10065 NY, USA. [email protected].
² Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, Milan, 20122, Italy. [email protected].
³ Cancer, Ageing, and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK. [email protected].
⁴ Cancer, Ageing, and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK.
⁵ Department of Medical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
⁶ MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.
⁷ Patologia Molecular de Neoplàsies Limfoides, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.
⁸ Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029, Madrid, Spain.
⁹ Barcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, 08036, Barcelona, Spain.
¹⁰ Department of Clinical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy.
¹¹ Unitat Hematopatologia, Hospital Clínic of Barcelona, Universitat de Barcelona, 08036, Barcelona, Spain.
¹² Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, Oviedo, 33003, Spain.
¹³ IUC-Oncopole, and CRCT INSERM U1037, 31100, Toulouse, France.
¹⁴ Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, 02215, MA, USA.
¹⁵ Veterans Administration Boston Healthcare System, West Roxbury, 02130, MA, USA.
¹⁶ Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, Milan, 20122, Italy. [email protected].
¹⁷ Department of Clinical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy. [email protected].

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum

Abstract

Publication types

Grants and funding